午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook Chinese Germany Japanese Korean

上海一飛生物科技有限公司 Company Information
Company Name:    Shanghai Yifei Biotechnology Co. , Ltd.
Tel:    021-65675885
Email:    customer_service@efebio.com
Nationality:    China
WebSite:    http://www.efebio.com
Product List:    11974
89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Product List
Basroparib 1858179-75-5
SU 5616 186611-58-5
Resomelagon 1809420-71-0
Berberine ursodeoxycholate 1868138-66-2
Propionic-2,2-d2 acid 19136-91-5
Diprogulic acid 18467-77-1
PF-06761281 1854061-19-0
BRD2492 1821669-43-5
Cofetuzumab 1869928-62-0
Cis-22a 1819366-84-1
SMO-IN-2 1822355-27-0
(R)-CJ 11974 187281-35-2
JTV-519 fumarate 1883549-36-7
Cbz-B3A 1884710-81-9
Mosunetuzumab 1905409-39-3
Fmoc-aminooxy-PEG2-NH2 190249-87-7
Acloproxalap 1824609-67-7
NTRC 0066-0 1817791-73-3
Linvencorvir 1808248-05-6
Iruplinalkib 1854943-32-0
NBI-27914 184241-44-9
3-phenylpropanoic-2,2-d2 acid 19136-97-1
1,4-Dideoxy-1,4-epithio-D-ribitol 190315-43-6
NS1-IN-1 181373-35-3
Aplindore Fumarate 189681-71-8
CXCR2-IN-2 1838123-21-9
Gedivumab 1807954-17-1
Lacnotuzumab 1831128-32-5
Tislelizumab 1858168-59-8
Omburtamab 1895083-75-6
Gatralimab 1826020-80-7
Gantofiban 183547-57-1
Ursolic aldehyde 19132-81-1
PF-06649298 1854061-16-7
Talacotuzumab 1826831-79-1
Naxitamab 1879925-92-4
Rezivertinib 1835667-12-3
Cibisatamab 1855925-27-7
FM04 1807320-40-6
Iladatuzumab 1906205-76-2
Enapotamab 1912423-61-0
Smurf-1 modulator CMP Example 20 1825371-51-4
CXCR2 antagonist 8 182498-30-2
Tisolagiline 1894207-44-3
GlyT1 Inhibitor 1 1820934-93-7
Azintuxizumab 1826819-57-1
Gilvetmab 1808081-43-7
N-Nitroso-N-methylaniline-d5 1821341-18-7
Zamaporvint 1900754-56-4
HDAC8-IN-20a 1884231-52-0
Tibulizumab 1849636-24-3
TriGalNAc CBz 186613-57-0
TAK-418 1818252-53-7
EPZ033294 1887195-17-6
Trifluoromethyl-tubercidin 1854086-05-7
(Iso)-Rilmakalim 184653-89-2
Tofimilast 185954-27-2
Dersalazine 188913-58-8
Mirikizumab 1884201-71-1
OPC-167832 1883747-71-4
PB1 188714-28-5
TRV-120027 acetate (1234510-46-3 free base) 1824712-70-0
L-161240 183298-68-2
Fentiazac 18046-21-4
YNT-185 dihydrochloride 1804978-82-2
Setrusumab 1847394-95-9
Loncastuximab 1875032-68-0
AY 77 1835734-92-3
(3S,4S)-PF-06459988 1858291-14-1
Lorundrostat 1820940-17-7
CJJ300 1807631-83-9
EM127 1886879-71-5
HS94 1892594-93-2
IACS-010759 hydrochloride 1807523-99-4
TBDMS-PEG4-Acid 1807540-77-7
Duvortuxizumab 1831098-91-9
Lesofavumab 1807960-57-1
MLT-985 1832576-25-6
YNT-185 1804978-81-1
Tyrosinase-IN-12 1860779-42-5
EGFR-IN-87 1835666-87-9
STC314 186295-19-2
Idelalisib D5 1830330-31-8
Edralbrutinib 1858206-58-2
Tinlarebant 1821327-95-0
NS-2710 184220-36-8
FFN 206 dihydrochloride 1883548-88-6
SDH-IN-2 1823354-06-8
Clenoliximab 182912-58-9
EPZ032597 1887193-58-9
PF-06737007 1863905-38-7
Anticonvulsant agent 10 HCl 1818253-48-3
cPrPMEDAP 182798-83-0
Cofrogliptin 1844874-26-5
Zavondemstat 1851412-93-5
MMPP 1895957-18-2
ZY-19489 1821293-40-6
hCYP3A4 Fluorogenic substrate 1 186299-00-3
Ezurpimtrostat hydrochloride 1914148-73-4
Br-PEG4-THP 1803547-60-5
89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007©  ChemicalBook. All rights reserved.